Clinical Trials Directory

Trials / Conditions / Stage IV Papillary Thyroid Cancer

Stage IV Papillary Thyroid Cancer

6 registered clinical trials studyying Stage IV Papillary Thyroid Cancer.

StatusTrialSponsorPhase
CompletedSuberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurr
NCT00134043
National Cancer Institute (NCI)Phase 2
CompletedTanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer
NCT00118248
National Cancer Institute (NCI)Phase 2
CompletedBortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Ther
NCT00104871
National Cancer Institute (NCI)Phase 2
CompletedRomidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radi
NCT00098813
National Cancer Institute (NCI)Phase 2
TerminatedSorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
NCT00095693
National Cancer Institute (NCI)Phase 2
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1